Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Medinox is the leader in NO-blocking therapeutics and is developing a broad technology platform to treat a wide variety of unmet medical needs including, sepsis, diabetes, adult respiratory distress syndrome (ARDS), and arthritis. In addition to its NO blocker technology, Medinox is developing new and safer NSAIDs and new therapeutics for sickle cell anemia. Medinox is currently evaluating its injectable NO blocker, NOX-100, in a multicenter Phase 1/2a clinical trial for the sepsis indication which is scheduled for completion in Q4 2002. ( www.medinox.com )
Medinox , Inc.
11575 Sorrento Valley Road Suite 201
San Diego, California 92121
USA
Tel: (858) 793-4820
Fax: (858) 793-4823